Landec Corp reports results for the quarter ended in May - Earnings Summary

Lifecore Biomedical

10/08/2022 23:26

* Landec Corp  LNDC.OQ  reported a quarterly adjusted loss
of 1
cent​​ per share for the quarter ended in May. The mean
expectation of five analysts for the quarter was for a loss of
one cent per share.
    * Revenue fell 65.9% to $47.63 million from a year ago;
analysts
expected $45.55 million. 
    * Landec Corp's reported EPS for the quarter was a loss of
$1.24​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Landec Corp shares had risen by 8.3% this quarter and
lost 2.7%
so far this year.
    * The company reported a quarterly loss of $36.47 million.
    * Wall Street's median 12-month price target for Landec Corp
is
$13.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 10
at 10:26 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 May. 31 2022      -0.01          -0.01          Met
 Feb. 28 2022      0.00           -0.08          Missed
 Nov. 30 2021      -0.04          0.05           Beat
 Aug. 31 2021      -0.12          -0.23          Missed